Exane Derivatives’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $481 | Sell |
12
-116
| -91% | -$4.65K | ﹤0.01% | 572 |
|
|
2022
Q1 | $4.78K | Sell |
128
-34
| -21% | -$1.27K | ﹤0.01% | 701 |
|
|
2021
Q4 | $6.45K | Sell |
162
-1,138
| -88% | -$45.3K | ﹤0.01% | 602 |
|
|
2021
Q3 | $48.4K | Sell |
1,300
-282
| -18% | -$10.5K | 0.01% | 604 |
|
|
2021
Q2 | $68.7K | Hold |
1,582
| – | – | 0.02% | 580 |
|
|
2021
Q1 | $74.9K | Hold |
1,582
| – | – | 0.02% | 451 |
|
|
2020
Q4 | $96.5K | Sell |
1,582
-2,009
| -56% | -$123K | 0.03% | 391 |
|
|
2020
Q3 | $168K | Buy |
3,591
+1,900
| +112% | +$88.8K | 0.05% | 210 |
|
|
2020
Q2 | $85.8K | Hold |
1,691
| – | – | 0.02% | 297 |
|
|
2020
Q1 | $75.4K | Sell |
1,691
-251
| -13% | -$11.2K | 0.02% | 300 |
|
|
2019
Q4 | $100K | Buy |
+1,942
| New | +$100K | 0.02% | 300 |
|